Drugs for the Heart: Expert Consult - Online and PrintDrugs for the Heart presents highly portable, up-to-date information on every drug class used to treat cardiovascular disease. Drs. Lionel H. Opie and Bernard J. Gersh put the latest dosages, interactions, indications and contraindications, side effects, and more at your fingertips, equipping you to make effective clinical decisions on behalf of your patients
|
Contents
1 βblocking agents | 1 |
2 Nitrates and newer antianginals | 38 |
3 Calcium channel blockers | 64 |
4 Diuretics | 93 |
5 Inhibitors of the reninangiotensinaldosterone system | 119 |
6 Heart failure | 169 |
7 Antihypertensive therapies | 224 |
Other editions - View all
Drugs for the Heart: Expert Consult - Online and Print Lionel H. Opie,Bernard J. Gersh Limited preview - 2013 |
Common terms and phrases
ablation ACE inhibitors activity acute coronary agents aldosterone amiodarone amlodipine angina angiotensin antiarrhythmic anticoagulation antihypertensive ARBs arrhythmias aspirin atrial fibrillation B-blockade B-blockers benefit bivalirudin bleeding blockers blood pressure cardiac cardiovascular events cardioversion CCBs cholesterol Circulation clinical clopidogrel Coll Cardiol combination contraindicated coronary artery dabigatran decreased diastolic digoxin diltiazem diuretic dose drugs dysfunction efficacy ejection fraction enzyme eplerenone first fondaparinux furosemide guidelines heart disease hemodynamic heparin hepatic hypertension hypokalemia hypotension increased inhibition inotropic insulin interactions intravenous ischemic ivabradine L.H. Opie Lancet LDL-C left ventricular levels lipid low-dose major metabolic metoprolol mg daily mg/day mg/dL mortality myocardial infarction nifedipine nitrates older adults oral outcomes patients placebo platelet postinfarct potassium prevention primary pulmonary randomised randomized receptor reduced renal risk factors side effects significant sinus sodium sotalol specific statin stroke systolic tachycardia therapy thiazide tion treatment trial type 2 diabetes vascular vasodilation verapamil versus warfarin